NIPH
DGX icon

NN Investment Partners Holdings’s Quest Diagnostics DGX Stock Holding History

NN Investment Partners Holdings’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$28.8M Buy
210,727
+46,992
+29% +$6.55M 0.16% 126
2021
Q4 		$28.3M Sell
163,735
-23,452
-13% -$3.57M 0.14% 126
2021
Q3 		$27.2M Buy
187,187
+43,597
+30% +$6.38M 0.15% 122
2021
Q2 		$18.9M Sell
143,590
-1,030
-0.7% -$135K 0.1% 174
2021
Q1 		$18.6M Buy
144,620
+30,139
+26% +$3.71M 0.11% 163
2020
Q4 		$13.6M Sell
114,481
-2,427
-2% -$296K 0.08% 211
2020
Q3 		$13.4M Sell
116,908
-12,912
-10% -$1.53M 0.09% 189
2020
Q2 		$14.8M Sell
129,820
-15,097
-10% -$1.6M 0.1% 172
2020
Q1 		$11.6M Sell
144,917
-18,607
-11% -$1.93M 0.1% 188
2019
Q4 		$17.5M Buy
163,524
+6,030
+4% +$629K 0.12% 173
2019
Q3 		$16.9M Buy
157,494
+43,845
+39% +$4.5M 0.13% 162
2019
Q2 		$11.6M Sell
113,649
-100,142
-47% -$9.62M 0.09% 199
2019
Q1 		$19.2M Buy
213,791
+139,737
+189% +$12.1M 0.15% 142
2018
Q4 		$6.17M Sell
74,054
-145,048
-66% -$13.6M 0.05% 250
2018
Q3 		$23.6M Sell
219,102
-26,421
-11% -$2.9M 0.17% 126
2018
Q2 		$27M Buy
245,523
+5,852
+2% +$610K 0.2% 113
2018
Q1 		$24M Buy
239,671
+143,354
+149% +$14.7M 0.17% 136
2017
Q4 		$9.49M Buy
96,317
+19,769
+26% +$1.87M 0.07% 219
2017
Q3 		$7.17M Sell
76,548
-162,339
-68% -$17.2M 0.05% 279
2017
Q2 		$26.6M Sell
238,887
-42,686
-15% -$4.51M 0.25% 110
2017
Q1 		$27.6M Sell
281,573
-54,345
-16% -$5.18M 0.26% 108
2016
Q4 		$30.9M Sell
335,918
-15,481
-4% -$1.33M 0.29% 98
2016
Q3 		$29.7M Sell
351,399
-66,266
-16% -$5.57M 0.28% 102
2016
Q2 		$34M Buy
417,665
+128,220
+44% +$9.76M 0.32% 97
2016
Q1 		$20.7M Buy
+289,445
New +$19.4M 0.2% 120

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

NN Investment Partners Holdings's DGX Position: Q1 2022 in Review

NN Investment Partners Holdings increased its Quest Diagnostics (DGX) stake by 29% in Q1 2022, buying an estimated $6.55M and bringing the position to 210,727 shares worth $28.8M. The position accounts for 0.16% of the portfolio, ranked #126.

NN Investment Partners Holdings first reported a position in DGX in Q1 2016 and has held it in 25 quarters since. The position peaked at $34M in Q2 2016. 852 funds tracked by Wall St. Rank hold DGX as of Q1 2022.

  • NN Investment Partners Holdings held 210,727 shares of Quest Diagnostics worth $28.8M as of Q1 2022.
  • NN Investment Partners Holdings bought 46,992 Quest Diagnostics shares in Q1 2022, an estimated $6.55M.
  • Quest Diagnostics made up 0.16% of NN Investment Partners Holdings's portfolio in Q1 2022, its #126 holding.
  • NN Investment Partners Holdings first reported a position in Quest Diagnostics in Q1 2016 and has held it in 25 quarters since.
  • NN Investment Partners Holdings's Quest Diagnostics position peaked at $34M in Q2 2016.
  • 852 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.

Based on NN Investment Partners Holdings's 13F filing for Q1 2022, filed 11 May 2022.